In this study, we carried out a systematical analysis by integrating available data from GEO and TCGA database, and validated the overexpression of ARNTL2 in human ccRCC clinical tissues and cell lines. This evidence concerns the gene BMAL2 and nonpapillary renal cell carcinoma.